Siemens Healthineers and Healthy.io Align Expertise to Improve Kidney Disease Compliance with Home Testing

  • The companies will integrate Siemens Healthineers urinalysis reagents into the Healthy.io’s smartphone-based urinalysis system.
  • With a home testing option for urinalysis, consumers can have the broadest possible access to albumin-to-creatinine ratio testing.
  • Greater access to urinalysis testing can help patients comply with physician instructions for frequent urinalysis tests to help improve patient outcomes overall.

Category:

Tuesday, October 23, 2018 8:30 am EDT

Dateline:

ERLANGEN, Germany

Public Company Information:

NQB:
SIEGY
"Siemens Healthineers has been a leader in urinalysis testing for 75 years, enabling healthcare professionals around the world to test for chronic kidney disease and other conditions from the point of care to the central lab"

ERLANGEN, Germany--(BUSINESS WIRE)--Siemens Healthineers and Healthy.io have announced today a global OEM alliance to help patients improve their compliance with Chronic Kidney Disease (CKD) monitoring. It is estimated that between 8-10 percent of the adult population globally have some form of kidney damage.1 Undetected CKD can lead to kidney failure, and also increase a patient’s risk of premature death from associated cardiovascular diseases. For these reasons, regular monitoring is important for improved patient outcomes. Periodic urine testing to monitor kidney function is traditionally performed in a clinician’s office and can be time consuming for patients. This alliance will offer patients a convenient alternative. Siemens Healthineers urinalysis reagents will integrate into Healthy.io’s smartphone-based urinalysis system to provide a home testing option, enabling the broadest possible access to albumin-to-creatinine ratio testing.

“Siemens Healthineers has been a leader in urinalysis testing for 75 years, enabling healthcare professionals around the world to test for chronic kidney disease and other conditions from the point of care to the central lab,” said Christoph Pedain, Executive Vice President, Point of Care Diagnostics, Siemens Healthineers. “This alliance expands our capabilities to improve patient experience by conducting testing in their home. Increased access to albumin-to-creatinine ratio testing—whether at home or at the physician’s office—is critical to reducing the economic burden of chronic disease and to improving patient outcomes.”

“Healthy.io is a pioneer in using computer vision and machine learning to transform the smartphone camera into a clinical grade medical device for improved patient access and convenience. Healthy.io and Siemens Healthineers share a vision for a future of healthcare, which sees consumers take greater control of their healthcare in a way that complements the existing clinician workflow,” said Yonatan Adiri, Founder & CEO, Healthy.io.

For information about the Siemens Healthineers and Healthy.io alliance, please visit https://healthy.io/.

1 https://www.worldkidneyday.org/faqs/chronic-kidney-disease/

Siemens Healthineers enables healthcare providers worldwide to increase value by empowering them on their journey towards expanding precision medicine, transforming care delivery, improving patient experience and digitalizing healthcare. A leader in medical technology, Siemens Healthineers is constantly innovating its portfolio of products and services in its core areas of diagnostic and therapeutic imaging and in laboratory diagnostics and molecular medicine. Siemens Healthineers is also actively developing its digital health services and enterprise services. In fiscal 2017, which ended on September 30, 2017, Siemens Healthineers generated revenue of €13.7 billion and adjusted profit of €2.5 billion and has about 48,000 employees worldwide. Further information is available at www.siemens-healthineers.com.

Contact:

Contact for journalists
Kimberly Nissen, Siemens Healthineers
Phone: +1 610 448-6355; Email: Kimberly.Nissen@siemens-healthineers.com